Martek Announces Second Quarter 2009 Financi...($665560 $645981 ...),Health

    Unaudited Condensed Consolidated Cash Flow Data

                                                         Six months ended
                                                         ----------------
                                                             April 30,
                                                          2009       2008
                                                          ----       ----

     Operating activities:
        Net income                                    $20,623     $17,871
        Non-cash items                                 27,671      24,611
        Changes in operating assets and liabilities,
         net                                          (22,663)     (3,726)
                                                       ------      ------
        Net cash provided by operating activities      25,631      38,756
                                                       ------      ------

     Investing activities:
        Purchase of investments and marketable
         securities, net                                    -     (10,850)
        Expenditures for property, plant and
         equipment                                     (5,263)     (3,576)
        Capitalization of intangible assets            (4,435)     (2,165)
                                                        -----      ------
      Net cash used in investing activities            (9,698)    (16,591)
                                                        -----      ------

     Financing activities:
        Repayments of notes payable and other
         long-term obligations, net                       (59)       (426)
       (Payments) proceeds from equity transactions,
         net                                             (425)      5,944
                                           
'/>"/>
SOURCE  Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 
Related medicine news :

1. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
2. Martek Announces Third Quarter 2007 Financial Results
3. Martek Announces Addition of lifesDHA(TM) to Entire Bellybar(TM) Line of Nutrition Bars
4. Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
5. Marteks lifesDHA(TM) Featured in New Beech-Nut(R) DHA Plus Baby Food and Cereals
6. Martek Wins German DHA Patent Infringement Actions Against Lonza and One of Nutrinovas Customers in Suits Relating to DHA Product Marketed for Use in Functional Foods and Dietary Supplements
7. Martek Signs Exclusive Worldwide Distributorship Agreement with Novus International
8. Marteks lifesDHA(TM) Featured in Dalco Foods Wellness Line Meat Products
9. Martek Announces Settlement of Class Action Lawsuit
10. Pocket Rocket Juice from Australias Boost Juice Features 700 mg of Marteks lifesDHA(TM)
11. Summary Notice of Proposed Settlement and Settlement Hearing in Re Martek Biosciences Corp., Securities Litigation